Opportunities for Opioid Safety and Community-Based Overdose Management

Size: px
Start display at page:

Download "Opportunities for Opioid Safety and Community-Based Overdose Management"

Transcription

1 Opportunities for Opioid Safety and Community-Based Overdose Management DANTE COLLINS ERICA C. ERNST MAYA DOE-SIMKINS SEPTEMBER 13, 2013

2 Overview Prevalence & data Overdose prevention Making an overdose plan Recognizing & responding to an overdose Experiences talking with drug users Additional organizational strategies

3

4 Some vocabulary Narcan = naloxone hydrochloride naloxone is NOT naltrexone (Vivitrol, Revia ) Suboxone = buprenorphine + naloxone naloxone -> discourage people from injecting Subutex = buprenorphine

5 Prevalence & data

6 NCHS, 2012

7 Mortality, overdose & homeless people Homeless people overall mortality rate 25 to 44-9x 45 to x Deaths from (comparable demographic) Homeless men- 16x higher Homeless women- 24x Baggett et al. JAMA Intern Med 2013

8 Macro strategies to address overdose Prescription monitoring programs (Paulozzi et al. Pain Medicine 2011) Prescription drug take back events (Gray et al. AIM 2012) Abuse deterrent formulations (Cicero et al. NEJM 2012) Safe opioid prescribing education (Albert et al. Pain Medicine 2011) Expansion of opioid agonist treatment (Clausen et al. Addiction 2009) Supervised injection facilities (Marshall et al. Lancet 2011) Take home naloxone (OEND) (Walley et al. BMJ 2013)

9 Tailoring the content We want to make sure we touch on questions & thoughts you have- what would you like to make sure we discuss today?

10 Preventing an overdose

11 Increased Risk Of Overdosing Mixing drugs Variation in strength and content of street drugs (purity) Tolerance changes (coming out of jail/tx) Using alone Physical health (liver function, weight loss, smoking, etc.) Transient living new dealers/new product Thinking you know everything Switching from sniffing/swallowing to injection

12 How Can You Lower Your Personal Risk Of Overdose? Stop using Engage in treatment Know your tolerance If relapse, start low and go slow Avoid mixing substances Use when others are around Train your network to call for help, rescue breathe, and administer naloxone Encourage your network to get a naloxone rescue kit Keep a kit where you use Tailor this plan to the client s situation

13 Sample Prevention Messages I want to remind you that (BECAUSE OF) your tolerance is very low, you are at high risk for an overdose Do you have an overdose plan? Do you and your friends know about naloxone? I don t want anything to happen to you If you relapse please do not do it alone People, places & things have a way of reappearing- it is my responsibility to make sure you have access to the skills & information to survive, no matter what happens

14 Strategies for preventing overdose Always use with someone else Always get your drugs from the same person Taste or use a smaller amount if a new provider Taste or use a smaller amount if you have been clean for a period (voluntary, hospitalization, incarceration) Don t mix with other drugs or ETOH Keep an overdose kit wherever you use Have an overdose plan

15 Making an overdose plan CHALLENGES PERSONAL PROCESS

16 OD plans affect: Individuals People around individuals v=_a_1qrohxw8u1frpjowtkw# action=share v=_a_1qrohxw8

17 Recognizing really high vs overdose Really high Pupils pinned Nodding, but arousable Responds to sternal rub Speech is slurred Sleepy, intoxicated, but breathing 8 or more times per minute Overdose Pupils pinned Not arousable No response to sternal rub Breathing slow or stopped Less than 8 times per minute May hear choking sounds or a gurgling/snoring noise Blue lips, blue fingertips >> Stimulate and observe >> Rescue breathe + give naloxone

18 Responding to an overdose

19 How do opioids affect breathing? Opioid Receptors, brain Opioid

20 If an overdose happens 1. Call 911 (you don t have to say that it is an OD) 2. Rescue breathing 3. Give naloxone 4. Keep breathing for the person?another dose of naloxone? (3-5 min) Rescue position

21 Rescue Position

22 How does naloxone affect overdose?

23 Experiences talking with fellow drug users

24 Some people are very interested in hearing more about overdose prevention Some people are not

25 More organizational strategies

26 Materials Referrals More ways to address overdose Ask clients/stakeholders what they want 911 Good Samaritan Make public space for overdose & join in

27 Message: Alive is more important than abstinent! Program restroom

28 PUD take care of each other: Drug using status of responders Enrollments Nondrug Users 31% Nondrug Users 13% Overdose rescues Drug Users* 69% Drug Users* 87% *Active + in treatment + in recovery Walley, BMJ, 2013

29 More ways to address overdose Address OD in counseling Mental health SUD Tx Upon entry Discharge planning Relapse prevention Screen for overdose risk Organize Rx disposal event Develop an organizational overdose policy Support dialogue & activism

30 Public displays; collective grief; tangible activism Lobbying for 911 Good Sam in MOquilt- 400

31 Public displays; collective grief; tangible activism Quilt detail

32 Public displays; collective grief; tangible activism International Overdose Awareness Day, Schaumberg

33 Public displays; collective grief; tangible activism Terri preparing for vigil

34 Public displays; collective grief; tangible activism OD vigil, Yarmouth

35 Public displays; collective grief; tangible activism Overdose Awareness Day, Gloucester

36 Public displays; collective grief; tangible activism 911 Good Samarian advocacy, NY

37 Ongoing remembrance; Increased awareness

38 Ongoing remembrance; Increased awareness

39 Ongoing remembrance; Increased awareness

40 Ongoing remembrance; Increased awareness

41 Ongoing remembrance; Increased awareness

42 Take home points Addressing overdose: Life affirming Enhances provider-patient relationship Response to fatalism Activates and soothes community members Creates community Sample policies? me:

43 MAYA DOE-SIMKINS ERICA C. ERNST DANTE COLLINS (773)

44 Overdose Education and Naloxone Distribution Program Reach 2010 States w/ OENDs 15 Programs 188 People enrolled 53,032 OD rescues 10,171 Wheeler E et al. Morb Mortal Wkly Rep 2012

45 Evaluations of OEND programs Feasibility Walley et al. JSAT 2013; 44:241-7 (Methadone and detox programs) Bennett et al. J Urban Health. 2011: 88; Enteen et al. J Urban Health 2010:87: Doe-Simkins et al. Am J Public Health 2009: 99: Piper et al. Subst Use Misuse 2008: 43; Increased knowledge and skills Wagner et al. Int J Drug Policy 2010: 21: Tobin et al. Int J Drug Policy 2009: 20; Green et al. Addiction 2008: 103; No increase in use, increase in drug treatment Seal et al. J Urban Health 2005:82: Wagner et al. Int J Drug Policy 2010: 21: Reduction in overdose in communities Maxwell et al. J Addict Dis 2006:25; Evans et al. Am J Epidemiol 2012; 174: Walley et al. BMJ 2013; 346: f174 Cost effective Coffin & Sullivan Ann Internal Med 2013; 158: 1-9

46 Reduction in community OD death rate Naloxone coverage per 100K Opioid overdose death rate 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 27% reduction 46% reduction No coverage ppl 100+ ppl Funding: CDC National Center for Injury Prevention and Control 1R21CE Walley, BMJ 2013

Comba&ng overdose and opioid poisoning death among people experiencing homelessness

Comba&ng overdose and opioid poisoning death among people experiencing homelessness James Kowalsky & Maya Doe- Simkins Midwest Harm Reduc0on Ins0tute Na&onal Health Care for the Homeless Conference & Policy Symposium May 28, 2014 Comba&ng overdose and opioid poisoning death among people

More information

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition Naloxone: Preventing Opioid Overdose in the Community Sharon Stancliff, MD Medical Director Harm Reduction Coalition DISCLOSURES Sharon Stancliff MD has nothing to disclose LEARNING OBJECTIVES 1. Discuss

More information

Reducing opioid overdose mortality: role of communityadministered

Reducing opioid overdose mortality: role of communityadministered Reducing opioid overdose mortality: role of communityadministered naloxone Vennus Ballen, MD, MPH; Lara Maldjian, MPH New York City Department of Health and Mental Hygiene Clinical Director s Network (CDN)

More information

Healthy Streets Outreach Program a program of Northeast Behavioral Health. 280 Union Street Lynn, ma

Healthy Streets Outreach Program a program of Northeast Behavioral Health. 280 Union Street Lynn, ma Healthy Streets Outreach Program a program of Northeast Behavioral Health 280 Union Street Lynn, ma 781-592- 0243 First things first slang Jammed, jambox, jam sandwich: really high Falling out: overdosing

More information

Comprehensive opioid safety initiatives and programming

Comprehensive opioid safety initiatives and programming Comprehensive opioid safety initiatives and programming Elizabeth Salisbury-Afshar Haven Wheelock Maya Doe-Simkins National Health Care for the Homeless Conference Portland, OR June, 2016 Please get permission

More information

Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction

Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction Coalition New York, NY Sleestan@gmail.com Strategies to

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand

More information

Understanding and Combating the Heroin Epidemic

Understanding and Combating the Heroin Epidemic Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the

More information

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including:

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including: Saves Lives The Solution A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including: PREVENTION & EDUCATION MONITORING & DIVERSION

More information

Naloxone Administration Training

Naloxone Administration Training Naloxone Administration Training Welcome! Welcome to the online training for naloxone administration The Presenter Dr. Joe Parks, Medical Director, Distinguished Professor, Missouri Institute for Mental

More information

1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care

1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care Michael W. Dailey, MD FACEP Chief, Division of Prehospital and Operational Medicine Associate Professor of

More information

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry

More information

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioid Use Disorder Treatment Initiation in Diverse Settings Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

How to Prevent an Opioid Overdose

How to Prevent an Opioid Overdose How to Prevent an Opioid Overdose MEDICAL CARE PROVIDERS: Providers can help reduce the likelihood of an opioid overdose by identifying patients who are at increased risk of opioid-induced respiratory

More information

7/7/2016 Journal of the American Medical Association,

7/7/2016 Journal of the American Medical Association, 1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of

More information

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018 Opioids 101 Washington Prevention Summit Alison Newman, MPH November 6, 2018 Opioids Class of drugs that work on the endorphin system. What are some examples? What are some of the risks? Opioid use disorder

More information

Opioids and Overdose 2017

Opioids and Overdose 2017 Opioids and Overdose 2017 This presentation is an introduction to: 1. Opioids, overdose and naloxone 2. How you can help A partnership of: Opioids A class of drugs taken for pain relief or euphoria. Prescribed

More information

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance Naloxone for Emergency Administration: A 2017 Update On FDA Guidance Nathan A. Painter, PharmD, CDE Associate Clinical Professor University of California San Diego Skaggs School of Pharmacy and Pharmaceutical

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

Naloxone Opioid Rescue Kits. Aaron Kochar, JD

Naloxone Opioid Rescue Kits. Aaron Kochar, JD Naloxone Opioid Rescue Kits Aaron Kochar, JD Common Opioids Codeine Lorcet Demerol Vicodin Oxycontin Hydrocodone Methadone Used as a Medication- Assisted Treatment Liquid methadone (difficult to divert/abuse)

More information

Responding to the Opioid Epidemic

Responding to the Opioid Epidemic Responding to the Opioid Epidemic Jessica Gray, MD Addiction Medicine Fellow Boston Medical Center ROME New England August 17, 2017 Disclosures for Jessica Gray, MD No conflicts Learning Objectives Describe

More information

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Alexander Y. Walley, MD, MSc Boston University School of Medicine ThINC Bergen 2015 Conference

More information

Welcome to the Opioid Overdose Prevention Project

Welcome to the Opioid Overdose Prevention Project Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize

More information

Opioid Overdose Education and Naloxone Distribution

Opioid Overdose Education and Naloxone Distribution Opioid Overdose Education and Naloxone Distribution Emily Stoukides, PharmD PGY-2 Ambulatory Care Pharmacy Resident Nicole Brunet, PharmD, BCPP Clinical Pharmacy Specialist, Mental Health Disclosures Emily

More information

Naloxone in Schools. Training for School Staff

Naloxone in Schools. Training for School Staff Naloxone in Schools Training for School Staff Objectives Learn the signs and symptoms of opioid drug overdose Have the skills to administer naloxone Review the use of naloxone protocol in responding to

More information

BROCKTON AREA S OPIOID OVERDOSE PREVENTION TRAINING

BROCKTON AREA S OPIOID OVERDOSE PREVENTION TRAINING BROCKTON AREA S OPIOID OVERDOSE PREVENTION TRAINING Mayor Carpenter s Office In collaboration with High Point Treatment Center Supported by the Massachusetts Opioid Abuse Prevention Collaborative Grant:

More information

Braintree Public Schools

Braintree Public Schools Braintree Public Schools Policy and Procedures for School Nurse, Athletic Director and Athletic Trainer Management of Potential Life Threatening Opioid Overdose Program Policy In order to recognize and

More information

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer,

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer, PROJECT TEAM Karen Tilashalski, 618-205-8134 Alison Donoho, 618-205-8129 Marianne Drainer, 618-205-8154 SR-Narcan@Chestnut.org PURPOSE of Training Get an overview of the opioid epidemic Reduce the risk

More information

Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation.

Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation. Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation. Alex H. Kral, PhD Director Behavioral and Urban Health Program RTI

More information

HARM REDUCTION & TREATMENT. Devin Reaves MSW

HARM REDUCTION & TREATMENT. Devin Reaves MSW HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that

More information

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD Objectives Provide an overview of harm reduction by defining shared language and key terms. Collaboratively

More information

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS Presented by: John M. Connolly, Ph.D. Acting Deputy Director Los Angeles County Health Agency Department of Public Health Substance Abuse Prevention

More information

Combating Opioid-related Overdose

Combating Opioid-related Overdose Combating Opioid-related Overdose Kelly Dunn, Ph.D. Assistant Professor Behavioral Pharmacology Research Unit Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine

More information

OPIATES WHAT'S THE PROBLEM?

OPIATES WHAT'S THE PROBLEM? OPIATES WHAT'S THE PROBLEM? WHAT CAN WE DO? Caleb Banta Green PhD MPH MSW Senior Research Scientist Alcohol and Drug Abuse Institute Affiliate Associate Professor School of Public Health Affiliate Faculty

More information

Overdose Response Training

Overdose Response Training Overdose Response Training Dave Morgan, RPh Safe Prescribing Consultant, Norfolk District Attorney s Office Daniel Muse, MD Brockton Hospital Sgt. Brian Holmes & Sgt. Donna McNamara Stoughton Police Department

More information

The Opioid Crisis: What Can Physicians Do About It?

The Opioid Crisis: What Can Physicians Do About It? The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures

More information

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD Skills and Knowledge on Overdose Prevention Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD Harm Reduction Coalition POLICY & ADVOCACY TRAINING & CAPACITY BUILDING OVERDOSE PREVENTION & ADVOCACY

More information

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction Harm Reduction Dennis Radloff Human Services Program Coordinator Substance Abuse Services Topics for Today Overview of harm reduction Sterile syringe access programs Preventing fatal opioid overdoses Working

More information

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South

More information

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased

More information

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs Monica Bharel, MD MPH Commissioner of Public Health Data For Massachusetts 2017 Q2 Quarterly Report and Chapter 55

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

Initiation and engagement in addiction treatment integrated into primary care: the role of gender

Initiation and engagement in addiction treatment integrated into primary care: the role of gender Initiation and engagement in addiction treatment integrated into primary care: the role of gender Alexander Y. Walley, MD, MSc Co-Authors: Kaylyn Duerfeldt, Joe Palmisano, Amy Sorensen-Alawad, Chris Chaisson,

More information

Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release

Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release Apryl L. Herron, MPH Clackamas County Public Health Division Kristen Watson, CADC II, QMHA Clackamas

More information

CMBHS Clinical Management of Behavioral Health Services

CMBHS Clinical Management of Behavioral Health Services Client: CMBHS Clinical Management of Behavioral Health Services Case Management AST022 Assessment Information Assessment Number Assessment Date Assessment Type Contact Type Assessment Site Referred By

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

Powell Recovery Center

Powell Recovery Center Powell Recovery Center Presentation for The Female Clergy Support Group of MD Powell Recovery Center, Inc. 14 South Broadway Baltimore, MD 21231 410-276-1773 Community Support is Key to the Success of

More information

Understanding Medication in Addiction Treatment for Drug Court Participants

Understanding Medication in Addiction Treatment for Drug Court Participants Understanding Medication in Addiction Treatment for Drug Court Participants Introduction This pocket guide is for drug court participants who may be prescribed or considering medication as a part of addiction

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

Take Home Naloxone: What Pharmacists Need to Know

Take Home Naloxone: What Pharmacists Need to Know Take Home Naloxone: What Pharmacists Need to Know Sheri L. Fandrey, BSP, PhD Knowledge Exchange Lead Manitoba Addictions Knowledge Exchange Conflict of Interest/Disclosure Dr. Sheri Fandrey Has no conflicts

More information

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Alexander Y. Walley, MD, MSc Associate Professor of Medicine Director, Addiction Medicine Fellowship Boston University

More information

Optimizing Safety in People with Addictions

Optimizing Safety in People with Addictions We encourage you to use these slides when teaching. If you do, please cite this source and note any changes made. - The Immersion Training in Addiction Medicine Program Optimizing Safety in People with

More information

Talking with your doctor

Talking with your doctor SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. September 2016 TRANSCRIPT

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. September 2016 TRANSCRIPT Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists September 2016 TRANSCRIPT Prescribe to Prevent Title Slide Welcome to Prescribe to Prevent: Overdose Prevention

More information

Improving the Quality of Addiction Treatment

Improving the Quality of Addiction Treatment Improving the Quality of Addiction Treatment Expanding Access to Medication-Assisted Treatment in Residential Addiction Treatment Programs Webinar sponsored by RTI International January 18, 2018 RTI International

More information

Medicaid and the Opioid Crisis

Medicaid and the Opioid Crisis Medicaid and the Opioid Crisis Erica Floyd Thomas Bureau Chief of Medicaid Policy Agency for Health Care Administration Presented to: Medical Care Advisory Committee March 20, 2018 1 Florida Medicaid Covers

More information

Community Pharmacy Distribution of Naloxone

Community Pharmacy Distribution of Naloxone Community Pharmacy Distribution of Naloxone College of Pharmacists of BC BC Centre for Disease Control Harm Reduction Program Sponsored in part by the BC Ministry of Health What is Naloxone? Naloxone is

More information

A Conversation on Fentanyl. School District 22 VERNON

A Conversation on Fentanyl. School District 22 VERNON A Conversation on Fentanyl School District 22 VERNON Why are we talking about this? In 2016 there were 922 unintentional overdose deaths in British Columbia 158 of those deaths occurred in Interior Health

More information

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

Identification and Treatment of Opioid Use Disorders in Primary Care Settings Identification and Treatment of Opioid Use Disorders in Primary Care Settings 17th Annual Primary Care Symposium February 24, 2018 Kelly S. Barth, DO Associate Professor, Psychiatry & Internal Medicine

More information

Boston's New Harm Reduction Program for Opioid Users Forges New Ground. July 28, 2016

Boston's New Harm Reduction Program for Opioid Users Forges New Ground. July 28, 2016 Boston's New Harm Reduction Program for Opioid Users Forges New Ground July 28, 2016 WHY THIS ISSUE? SPEAKERS TODAY Boston HCH Program (BHCHP): Jessie Gaeta, MD, Chief Medical Officer Joanne Guarino, Chair,

More information

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Opioid Epidemic Prescription Opiods Can be prescribed by doctors to treat moderate to severe pain, but can also have serious risks and side

More information

Opioid Use in Youth. Amy Yule M.D. March 2,

Opioid Use in Youth. Amy Yule M.D. March 2, Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin

More information

Patient Information Leaflet

Patient Information Leaflet Page 25 Patient Information Leaflet PATIENT INFORMATION SUBOXONE (sub-ox-own) (buprenorphine HCl/naloxone HCl dihydrate, sublingual tablet) (C*) SUBUTEX (SUB-u-tex) (buprenorphine HCl, sublingual tablet)

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Overdose Prevention and Response and Relay, a post-overdose initiative

Overdose Prevention and Response and Relay, a post-overdose initiative Overdose Prevention and Response and Relay, a post-overdose initiative Emily Winkelstein, Community Engagement Manager Bureau of Alcohol and Drug Use Prevention, Care and Treatment Agenda How overdose

More information

TO YOUR PHARMACIST TOOLKIT. A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids

TO YOUR PHARMACIST TOOLKIT. A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids TALK TO YOUR PHARMACIST TOOLKIT A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids Acknowledgements This report was made possible by the following individuals and agencies: Stephanie

More information

Closing the Loop in Treating Opioid Addiction:

Closing the Loop in Treating Opioid Addiction: Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:

More information

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics

More information

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health Protecting, Leading, Uniting Since 1893 Law Enforcement Naloxone Training Florida Department of Children and Families Office of Substance Abuse and Mental Health 1. Learn how to recognize and respond to

More information

MEDICATION ASSISTED TREATMENT

MEDICATION ASSISTED TREATMENT MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone

More information

Recovery U: Medication Assisted Treatment (MAT)

Recovery U: Medication Assisted Treatment (MAT) Recovery U: Medication Assisted Treatment (MAT) MS. TIKKANEN: Welcome to the Recovery U Online Learning Community for Understanding Medication-Assisted Treatment. This is Skye Tikkanen. I am a clinical

More information

Changing Course: statewide efforts to combat the opioid epidemic in California

Changing Course: statewide efforts to combat the opioid epidemic in California Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Medical Assisted Treatment of Opioid

Medical Assisted Treatment of Opioid Medical Assisted Treatment of Opioid Dependence with XR-NTX(Vivitrol) Michael McNamara DO, FACN Medical Director Mental Health Center of Greater Manchester Manchester NH Outline Overview of Opioid Dependence

More information

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids Emily Junck, MD Hayes Wong, MD Paul Freeman, MD Special Guest: Caleb Banta-Green, PhD, MPH, MSW Special

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

DHCS Tribal MAT Project

DHCS Tribal MAT Project DHCS Tribal MAT Project Melissa Eidman & Valentine Antony California Consortium for Urban Indian Health August 2018 CaliforniaConsortiumforUrbanIndianHealth CCUIH StrengtheningTheOrganizationsThatStrengthenOurCommunities

More information

Opioids - Fentanyl - Naloxone. Public Health Nurse

Opioids - Fentanyl - Naloxone. Public Health Nurse Opioids - Fentanyl - Naloxone Public Health Nurse What are Opioids? Opioids are a family of drugs that treat pain and can cause sleepiness. Prescription (legal) Opioids fall into 3 main categories: 1.

More information

Opioid Use Disorders &Medication Treatment

Opioid Use Disorders &Medication Treatment Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review

More information

Brain Injury, Overdose, and Harm Reduction. Laura Bartolomei-Hill, LMSW September 24, 2018

Brain Injury, Overdose, and Harm Reduction. Laura Bartolomei-Hill, LMSW September 24, 2018 Brain Injury, Overdose, and Harm Reduction Laura Bartolomei-Hill, LMSW September 24, 2018 Where I m coming from I am currently a social worker in two settings: Inpatient Psychiatry Department at the University

More information

State Opioid Response (SOR) Grant

State Opioid Response (SOR) Grant State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics

More information

Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA

Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA 94612 wheeler@harmreduction.org Drug Overdose Deaths in the US: In 2014, there were 47,055 drug overdose deaths in

More information

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers DISCLOSURES None. OVERVIEW Basic description- context and system overview

More information

Opioid Overdose Preparedness & Response in Congregate Housing & Shelters

Opioid Overdose Preparedness & Response in Congregate Housing & Shelters Opioid Overdose Preparedness & Response in Congregate Housing & Shelters This document was developed by the Boston Health Care for the Homeless Program in partnership with the Boston Public Health Commission.

More information

Overdose Prevention, Recognition & Response Education Train-the-Trainer

Overdose Prevention, Recognition & Response Education Train-the-Trainer Overdose Prevention, Recognition & Response Education Train-the-Trainer Bernie Lieving, MSW Overdose Prevention Education Coordinator Santa Fe Prevention Alliance & Office of Substance Abuse Prevention

More information

Naloxone for Opioid Safety

Naloxone for Opioid Safety Naloxone for Opioid Safety Phillip O. Coffin, MD MIA San Francisco Department of Public Health University of California San Francisco Disclosure Information Gilead, Donated ledipasvir-sofosbuvir, Study,

More information

Economic Costs of Substance Abuse Dheeraj Raina, MD

Economic Costs of Substance Abuse Dheeraj Raina, MD Economic Costs of Substance Abuse Dheeraj Raina, MD Medical Director, Anthem Annual U.S. Economic Cost of Substance Use Disorders (SUD) In $ (millions) $168 Healthcare $26 $11 $27 $79 $193 $249 $300 Crime

More information

ADOLESCENTS, YOUNG ADULTS AND OPIOID USE: WHEN IS IT A PROBLEM? WHAT TO DO?

ADOLESCENTS, YOUNG ADULTS AND OPIOID USE: WHEN IS IT A PROBLEM? WHAT TO DO? ADOLESCENTS, YOUNG ADULTS AND OPIOID USE: WHEN IS IT A PROBLEM? WHAT TO DO? HOSTED BY: ADOLESCENT SBIRT PROJECT, NORC at THE UNIVERSITY OF CHICAGO, and THE BIG SBIRT INITIATIVE Webinar Moderator Tracy

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information